Study of DP303c Administered Intravenously to Subjects With HER2-Positive in Advanced Solid Tumors
Clinical trial NCT04146610 · UNKNOWN
Trial details
- NCT number
- NCT04146610
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-01
- Primary completion
- 2021-06-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.